Clinical Trial Update: Warfarin and Antiplatelet Therapy in Chronic Heart Failure [Phase 3]

View source ↗

Summary

Phase 3 trial update on warfarin plus antiplatelet therapy for chronic heart failure has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Antiplatelet therapy (antiplatelet agents)
• Warfarin (warfarin)

Snippet

Sponsor: US Department of Veterans Affairs | Conditions: Heart Failure | Phase 3 | Status: COMPLETED